CNSP icon

CNS Pharmaceuticals

7 hedge funds and large institutions have $55.2K invested in CNS Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 15 closing their positions.

Holders
7
Holders Change
-13
Holders Change %
-65%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
Reduced
4
Closed
15
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
UBS Group
1
UBS Group
Switzerland
$32.6K 23,978 -40,440 -63%
GSC
2
Ground Swell Capital
South Carolina
$15.4K 11,341 +11,341 New
TRCT
3
Tower Research Capital (TRC)
New York
$6.95K 5,111 +5,111 New
BC
4
Barrett & Company
Rhode Island
$136 100 +100 New
MCM
5
MAI Capital Management
Ohio
$55 40 -1,960 -98%
SS
6
SBI Securities
Japan
$20 15 -90 -86%
Bank of America
7
Bank of America
North Carolina
$12 9 -431 -98%
Jane Street
8
Jane Street
New York
-419,737 Closed
Geode Capital Management
9
Geode Capital Management
Massachusetts
-387,064 Closed
Citadel Advisors
10
Citadel Advisors
Florida
-321,874 Closed
XT
11
XTX Topco
Cayman Islands
-294,919 Closed
CCM
12
Connective Capital Management
California
-280,055 Closed
IWC
13
Integrated Wealth Concepts
Massachusetts
-250,000 Closed
VF
14
Virtu Financial
New York
-162,349 Closed
HF
15
HRT Financial
New York
-156,007 Closed
Two Sigma Investments
16
Two Sigma Investments
New York
-93,077 Closed
Goldman Sachs
17
Goldman Sachs
New York
-40,329 Closed
SIM
18
Synergy Investment Management
Florida
-9 Closed
Wells Fargo
19
Wells Fargo
California
-4 Closed
PA
20
Parallel Advisors
California
-1 Closed
PMFA
21
Plante Moran Financial Advisors
Michigan
-1 Closed
DWM
22
Dogwood Wealth Management
Kansas
-1 Closed
CFGS
23
Concourse Financial Group Securities
Alabama